Yusuke Morita

发表

Hepatitis C virus eradication ameliorates the prognosis of advanced hepatocellular carcinoma treated with sorafenib

A. Masumoto, M. Yada, K. Motomura, 2022, Journal of viral hepatitis.

Serum α‐fetoprotein level at treatment completion is a useful predictor of hepatocellular carcinoma occurrence more than one year after hepatitis C virus eradication by direct‐acting antiviral treatment

A. Masumoto, M. Yada, K. Motomura, 2021, Journal of viral hepatitis.

Liver abscess due to Fusobacterium caused by dental bacterial infection: report of two cases

A. Masumoto, M. Yada, K. Motomura, 2013 .

Recombinant human soluble thrombomodulin ameliorates acetaminophen-induced liver toxicity in mice.

T. Ohashi, M. Kohjima, Y. Ogawa, 2019, Experimental and therapeutic medicine.

Therapeutic efficacy of lenvatinib for hepatocellular carcinoma with iso-high intensity in the hepatobiliary phase of Gd-EOB-DTPA-MRI

A. Masumoto, M. Yada, K. Motomura, 2021, Molecular and clinical oncology.

A case of granulocyte colony-stimulating factor-producing intrahepatic sarcomatoid cholangiocarcinoma

Y. Ohishi, A. Masumoto, M. Yada, 2021, Clinical Journal of Gastroenterology.

Serum zinc levels in cancer patients are low and difficult to elevate when complicated by liver cirrhosis: A retrospective study

Lingaku Lee, M. Hijioka, R. Sugimoto, 2023, Medicine.

Multicentric recurrence of intraductal papillary neoplasm of bile duct after spontaneous detachment of primary tumor: A case report

A. Masumoto, M. Yada, K. Motomura, 2022, World journal of clinical cases.

Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma.

A. Masumoto, M. Yada, K. Motomura, 2014, World journal of gastroenterology.